Abstract
Stenting is an important treatment option for pulmonary artery stenosis (PS) associated with congenital heart disease (CHD). However, no stent has been approved for this indication in Japan, despite negotiation between academia and the regulatory bodies for longer than 20 years. To evaluate efficacy and safety of the CP stent, we performed the first investigator-initiated clinical trial for pediatric interventional cardiology in Japan. This trial was designed as a single-arm, prospective, clinical trial. Patients who had postoperative PS associated with CHD were included. Stenting was attempted in 24 cases and succeeded in 22 cases. The median age of the patients was 11 years (3–36 years) and weight was 38 kg (12–69 kg), while follow-up for 12 months was completed. In all 22 cases, stenting was successful, with a 50% increase in the minimum lumen diameter (MLD) in 86.4% of patients (90% confidence interval, 68.4–96.2%). The mean percent change in MLD was 119.3 ± 52.5%. In two-ventricle repair, the mean percent change in systolic right ventricular/aortic pressure was − 8.5 ± 16.1%, while that of pressure gradient was − 55.9 ± 41.7%. In single-ventricle repair, the percent change in the mean pressure gradient was − 100.0 ± 0%, while that of SaO2 was 1.4 ± 1.7%. No serious adverse events or significant restenosis was reported. The CP stent is highly effective and safe for PS associated with CHD. This study has significant importance in not only scientific but also social considerations.
Similar content being viewed by others
References
Garson A Jr, Nihill MR, McNamara DG, Cooley DA (1979) Status of the adult and adolescent after repair of tetralogy of Fallot. Circulation 59:1232–1240
Myers PO, Tissot C, Beghetti M (2014) Assessment of operability of patients with pulmonary arterial hypertension associated with congenital heart disease. Circ J 78:4–11
Oyen WJ, van Oort AM, Tanke RB, van Mill GJ, Aengevaeren WR, Corstens FH (1995) Pulmonary perfusion after endovascular stenting of pulmonary artery stenosis. J Nucl Med 36:2006–2008
Chaturvedi RR, Kilner PJ, White PA, Bishop A, Szwarc R, Redington AN (1997) Increased airway pressure and simulated branch pulmonary artery stenosis increase pulmonary regurgitation after repair of tetralogy of Fallot. Real-time analysis with a conductance catheter technique. Circulation 95:643–649
Feltes TF, Bacha E, Beekman RH 3rd, Cheatham JP, Feinstein JA, Gomes AS, Hijazi ZM, Ing FF, de Moor M, Morrow WR, Mullins CE, Taubert KA, Zahn EM (2011) Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation 123:2607–2652
Tomita H, Nakanishi T, Hamaoka K, Kobayashi T, Ono Y (2010) Stenting in congenital heart disease: medium- and long-term outcomes from the JPIC stent survey. Circ J 74:1676–1683
Fujii T, Tomita H, Fujimoto K, Otsuki S, Kobayashi T, Ono Y, Yazaki S, Kim SH, Nakanishi T (2016) Morphological and hemodynamic effectiveness of stenting for pulmonary artery stenosis—subanalysis of JPIC stent survey. Circ J 80:1852–1856
Fujii T, Tomita H, Fujimoto K, Otsuki S, Kobayashi T, Ono Y, Yazaki S, Kim SH, Nakanishi T (2014) Stenting for pulmonary artery stenosis complicated by univentricular physiology: subanalysis of JPIC stent survey. J Cardiol 64:324–327
Fujii T, Tomita H, Fujimoto K, Otsuki S, Kobayashi T, Ono Y, Yazaki S, Kim SH, Nakanishi T (2016) Current trends in stenting for aortic coarctation in Japan: subanalysis of Japanese Society of Pediatric Interventional Cardiology (JPIC) stent survey. Pediatr Int 58:100–104
Ewert P, Schubert S, Peters B, Abdul-Khaliq H, Nagdyman N, Lange PE (2005) The CP stent—short, long, covered—for the treatment of aortic coarctation, stenosis of pulmonary arteries and caval veins, and Fontan anastomosis in children and adults: an evaluation of 60 stents in 53 patients. Heart 91:948–953
Agnoletti G, Marini D, Ou P, Vandrell MC, Boudjemline Y, Bonnet D (2009) Cheatham platinum (CP) and Palmaz stents for cardiac and vascular lesions treatment in patients with congenital heart disease. EuroIntervention 4:620–625
Meadows J, Minahan M, McElhinney DB, McEnaney K, Ringel R (2015) Intermediate outcomes in the prospective, multicenter Coarctation of the Aorta Stent Trial (COAST). Circulation 131:1656–1664
Taggart NW, Minahan M, Cabalka AK, Cetta F, Usmani K, Ringel RE (2016) Immediate outcomes of covered stent placement for treatment or prevention of aortic wall injury associated with coarctation of the aorta (COAST II). JACC Cardiovasc Interv 9:484–493
Yoshimoto J, Inuzuka R, Matsui H, Kim SH, Miyata H, Suda K, Sugiyama H, Tomita H, Yazaki S, Kobayashi T, Otsuki S (2018) Pediatric and congenital catheter interventions and ablations in Japan during 2017: Annual report from Japanese Pediatric Interventional Society Database (JPIC-DB). J JPIC 3:43–55
Rothman A, Perry SB, Keane JF, Lock JE (1990) Early results and follow-up of balloon angioplasty for branch pulmonary artery stenoses. J Am Coll Cardiol 15:1109–1117
Shaffer KM, Mullins CE, Grifka RG, O'Laughlin MP, McMahon W, Ing FF, Nihill MR (1998) Intravascular stents in congenital heart disease: short- and long-term results from a large single-center experience. J Am Coll Cardiol 31:661–667
Fogelman R, Nykanen D, Smallhorn JF, McCrindle BW, Freedom RM, Benson LN (1995) Endovascular stents in the pulmonary circulation. Clinical impact on management and medium-term follow-up. Circulation 92:881–885
Hosking MC, Thomaidis C, Hamilton R, Burrows PE, Freedom RM, Benson LN (1992) Clinical impact of balloon angioplasty for branch pulmonary arterial stenosis. Am J Cardiol 69:1467–1470
Acknowledgements
This research is supported by the Project Promoting Clinical Trials for Development of New Drugs and Medical Devices (Japan Medical Association) from Japan Agency for Medical Research and Development, AMED. We thank Ellen Knapp, PhD, from Edanz Group (https://www.edanzediting.com/ac) for editing a draft of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Fujii, T., Tomita, H., Kobayashi, T. et al. Clinical trial of the CP stent for pulmonary artery stenosis: the first investigator-initiated clinical trial for pediatric interventional cardiology in Japan. Heart Vessels 36, 291–296 (2021). https://doi.org/10.1007/s00380-020-01691-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-020-01691-0